Keywords: posting, solid, 2nd-qtr, results, astrazeneca, announces, another
Posting solid 2nd-qtr results, AstraZeneca announces another cost-cutting program
Article | 06 August 2007
Despite what were generally viewed as a solid set of second-quarter 2007 results, Anglo-Swedish pharmaceutical major AstraZeneca revealed a second restructuring ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
